Infinium Pharmachem Limited (NSE:INFINIUM)

India · Delayed Price · Currency is INR

217.00

+0.10 (0.05%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Intermediate Chemicals	1.52B	1.34B	1.14B	991.19M	547.59M
Intermediate Chemicals Growth	13.84%	17.18%	15.24%	81.01%	50.32%
Biocall	33.25M	18.06M	-	-	-
Biocall Growth	84.10%	-	-	-	-
Total	1.56B	1.36B	1.14B	991.19M	547.59M
Total Growth	14.78%	18.76%	15.24%	81.01%	50.32%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
India	1.36B	1.18B	826.92M	726.35M	373.50M
India Growth	15.71%	42.18%	13.85%	94.47%	103.49%
Export	159.25M	175.23M	290.48M	256.62M	172.19M
Export Growth	-9.12%	-39.67%	13.19%	49.03%	-2.63%
SEZ	12.09M	5.62M	24.86M	8.23M	-
SEZ Growth	115.18%	-77.39%	202.16%	-	-
Unallocated	25.25M	-	-	-	-
Total	1.56B	1.36B	1.14B	991.19M	545.68M
Total Growth	14.78%	18.76%	15.24%	81.64%	51.42%

Source: S&P Global Market Intelligence.